Researcher
Peter Carmeliet
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Cardiac and vascular medicine
- See also: Peter Carmeliet (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Carmeliet Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → 30 Sep 2005
Projects
1 - 10 of 110
- Angiogenesis and Vascular HeterogeneityFrom9 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory role of graft endothelial cells to improve organ transplantationFrom30 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Demystifying the mystery genome for alternative immunotherapy targets: combining artificial intelligence-based discovery of immunomodulatory endothelial cell targets and in vivo target validation.From1 Oct 2022 → 30 Sep 2023Funding: BOF - postdoctoral mandates
- DEMYSTIFYING ALTERNATIVE IMMUNOTHERAPY MYSTERY TARGETS BY COMBINING ARTIFICIAL INTELLIGENCE- BASED TARGET DISCOVERY AND LARGER-SCALE TARGET VALIDATIONFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory endothelial cells (IMECs): dissecting their immunosuppressive / im- munostimulatory features via nanoparticle-based gene silencing or overexpressionFrom26 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validating novel AI-predicted targets for alternative cancer immunotherapyFrom20 Sep 2022 → TodayFunding: FWO fellowships, Foundations, funds and other with scientific goal
- Angiogenesis and Vascular HeterogeneityFrom19 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metabolic and epigenetic interplay in neural progenitor cells: investigating neurodevelopmental disorders associated with impaired neural progenitor cell expansion (MEPIcephaly).From1 Jun 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Imaging the invisible in preclinical models using magnetic particle imagingFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
41 - 50 of 587
- Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis(2022)
Authors: Diede Houbaert, Maria Livia Sassano, Mila Borri, Jelle Verhoeven, Madhur Agrawal, Gabriele Bergers, Bart Ghesquière, Mieke Dewerchin, Johan Swinnen, Peter Carmeliet, et al.
- PHGDH heterogeneity potentiates cancer cell dissemination and metastasis(2022)
Authors: Margherita Demicco, Ginevra Doglioni, Anke Vandekeere, Alex Cuadros, David Nittner, Francesca Rizzollo, Panagiotis Karras, dorien Broekaert, Sofie Demeyer, Guy Eelen, et al.
Pages: 747 - + - A Role for the Vascular Endothelium in Post-Acute COVID-19?(2022)
Authors: Laura De Rooij, Peter Carmeliet
Pages: 1503 - 1505 - Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling(2022)
Authors: Peter Carmeliet
Pages: 1232 - 1246 - Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes(2022)
Authors: Max Mazzone, Peter Carmeliet
- De novo serine synthesis regulates chondrocyte proliferation during bone development and repair(2022)
Authors: Steve Stegen, Shauni Loopmans, Peter Carmeliet, Geert Carmeliet
- Angiogenesis goes computational - The future way forward to discover new angiogenic targets?(2022)
Authors: Léo Bettoni, Peter Carmeliet
Pages: 5235 - 5255 - THE ROLE OF THE ENDOTHELIUM IN CYSTIC FIBROSIS ASSOCIATED LIVER DISEASE(2021)
Authors: Mathias Declercq, Peter Witters, Lucas Treps, Peter Carmeliet
- The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors(2021)
Authors: Alexandra De Zutter, Helena Crijns, Paulien Verscheure, Peter Carmeliet, Jo Van Damme, Paul Proost, Sofie Struyf
- Hierarchical imaging and computational analysis of three-dimensional vascular network architecture in the entire postnatal and adult mouse brain(2021)
Authors: Peter Carmeliet
Pages: 4564 - +
Patents
1 - 10 of 10
- Carnitine palmitoyltransferase 1 inhibitors for inhibition of pathological angiogenesis (Inventor)
- Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor (Inventor)
- Inhibition of plgf to treat philadelphia chromosome positive leukemia (Inventor)
- Means and methods for treating lung hypoplasia (Inventor)
- Use of VEGF and homologues to treat neuron disorders (Inventor)
- Novel anti-PLGF antibody (Inventor)
- Anti-angiogenic therapy (Inventor)
- Responsiveness to angiogenesis inhibitors (Inventor)
- GLUTAMINE SYNTHETASE INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS (Inventor)
- CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS (Inventor)